Usai, Carla http://orcid.org/0000-0002-6373-2765
Ainsua-Enrich, Erola
Gales, Victor Urrea http://orcid.org/0000-0002-2577-856X
Pradenas, Edwards http://orcid.org/0000-0001-5162-8920
Lorca-Oró, Cristina
Tarrés-Freixas, Ferran
Roca, Núria
Pérez, Mónica
Ávila-Nieto, Carlos
Rodríguez de la Concepción, María Luisa
Pedreño-Lopez, Núria http://orcid.org/0000-0001-6927-2301
Carabelli, Julieta http://orcid.org/0000-0003-2329-3996
Trinité, Benjamin http://orcid.org/0000-0003-3809-042X
Ballana, Ester
Riveira-Muñoz, Eva
Izquierdo-Useros, Nuria http://orcid.org/0000-0002-1039-1821
Clotet, Bonaventura
Blanco, Julià http://orcid.org/0000-0002-2225-0217
Guallar, Victor
Cantero, Guillermo
Vergara-Alert, Júlia
Carrillo, Jorge http://orcid.org/0000-0003-0221-5948
Segalés, Joaquim http://orcid.org/0000-0002-1539-7261
Article History
Received: 14 August 2023
Accepted: 9 February 2024
First Online: 27 February 2024
Competing interests
: No potential conflict of interest was reported by the authors. Unrelated to the submitted work, JB and JC are founders and shareholders of AlbaJuna Therapeutics, S.L. BC is founder and shareholder of AlbaJuna Therapeutics, S.L. and AELIX Therapeutics, S.L, and V.G is founder and shareholder of Nostrum Biodiscovery.